NCT05234801

Brief Summary

A retrospective post-market data collection study of the following implant devices :

  • DARCO™ Headed Cannulated Screw
  • ORTHOLOC™ 3Di Recon-Midfoot/Flatfoot System
  • ORTHOLOCTM 3Di 2 Foot Reconstruction System: CROSSCHECK™ Module

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 20, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 10, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

March 30, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2022

Completed
Last Updated

May 24, 2022

Status Verified

May 1, 2022

Enrollment Period

3 months

First QC Date

January 20, 2022

Last Update Submit

May 17, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • To demonstrate the performance of the devices concerned.

    Device related intra and post operative adverse events

    1 year.

  • To demonstrate the safety of the devices concerned.

    Device related intra and post operative adverse events

    3 months

Study Arms (3)

DARCO™ Headed Cannulated Screw

Patients who received a device from the DARCO™ Headed Cannulated Screw family of devices during routine lower limb surgery.

Device: DARCO™ Headed Cannulated Screw

ORTHOLOC™ 3Di Recon-Midfoot/Flatfoot System

Patients who received a device from the ORTHOLOC™ 3Di Recon-Midfoot/Flatfoot System family of devices during routine lower limb surgery.

Device: ORTHOLOC™ 3Di Recon-Midfoot/Flatfoot System

ORTHOLOCTM 3Di 2 Foot Reconstruction System: CROSSCHECK™ Module

Patients who received a device from the ORTHOLOCTM 3Di 2 Foot Reconstruction System: CROSSCHECK™ Module family of devices during routine lower limb surgery.

Device: ORTHOLOCTM 3Di 2 Foot Reconstruction System: CROSSCHECK™ Module

Interventions

The DARCO™ Headed Cannulated Screw is a multi-size screw system designed to be used over a guide pin or wire with instrumentation to provide interfragmentary compression and stability for bone fracture/fragment fixation.

DARCO™ Headed Cannulated Screw

A multi-indication foot reconstruction solution providing indication specific implants and instruments designed to address the unique demands of the forefoot and midfoot.

ORTHOLOC™ 3Di Recon-Midfoot/Flatfoot System

A comprehensive fixation system consisting of a wide variety of plate options, created with the purpose of stabilization and fixation of fractures, revision procedures, joint fusion and reconstruction of small bones of the feet.

ORTHOLOCTM 3Di 2 Foot Reconstruction System: CROSSCHECK™ Module

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Retrospective data collection from those who have received the interested devices during lower limb surgery at this single centre.

You may qualify if:

  • Patients 18 years or older at the time of index procedure
  • Patients who previously received:
  • the Charlotte™ MUC Screw System in accordance with the indications for use: for fixation of bone fractures or for bone reconstruction.
  • the CROSSCHECKTM in accordance with the indications for use: Stabilization of fresh fractures, revision procedures, joint fusion and reconstruction of small bones of the feet.
  • the ORTHOLOC™ 3Di Recon-Midfoot/Flatfoot System in accordance with the indications for use: Stabilization of fresh fractures, revision procedures, joint fusion and reconstruction of small bones of the feet.
  • a DARCO™ Headed Cannulated Screw in accordance with the indications for use: for bone fracture fixation and bone fragment fixation.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust

Oswestry, Shropshire, SY10 7AG, United Kingdom

Location

Study Officials

  • Andrew Bing, FRCS

    Robert Jones and Agnes Hunt Orthopaedic Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 20, 2022

First Posted

February 10, 2022

Study Start

March 30, 2022

Primary Completion

June 30, 2022

Study Completion

July 30, 2022

Last Updated

May 24, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

No plan to share the raw retrospective data collected from routine clinical assessments following lower limb surgery.

Locations